These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20307571)

  • 21. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retrospective study of cases of neuromeningeal cryptococcosis at the University Hospital of Bobo Dioulasso since accessibility to antiretroviral in Burkina Faso].
    Bamba S; Barro-Traoré F; Sawadogo E; Millogo A; Guiguemdé RT
    J Mycol Med; 2012 Mar; 22(1):30-4. PubMed ID: 23177811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of Antiretroviral Therapy in Cryptococcal Meningitis: What We Can (and Cannot) Learn From Observational Data.
    Boulware DR; Jarvis JN
    Clin Infect Dis; 2023 Jul; 77(1):74-76. PubMed ID: 36883585
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa.
    Stadelman AM; Ssebambulidde K; Tugume L; Pastick KA; Hullsiek KH; Lofgren S; Nuwagira E; Evans EE; Williams DA; Muzoora C; Meya DB; Rajasingham R; Rhein J; Boulware DR
    Med Mycol; 2021 Jul; 59(7):712-719. PubMed ID: 33399865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy after cryptococcal meningitis.
    Hirsch HH; Wehrle-Wieland E; Battegay M
    N Engl J Med; 2014 Sep; 371(12):1166. PubMed ID: 25229931
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral therapy after cryptococcal meningitis.
    Drain PK; Moosa Y; Powderly WG
    N Engl J Med; 2014 Sep; 371(12):1165. PubMed ID: 25229930
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiretroviral therapy after cryptococcal meningitis.
    Boulware DR; Meya DB
    N Engl J Med; 2014 Sep; 371(12):1166-7. PubMed ID: 25229929
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cryptococcal neuromeningitidis in HIV-infected patients in Bangui, in the era of antiretroviral treatment].
    Gbangba-Ngai E; Fikouma V; Mossoro-Kpinde CD; Tekpa G; Ouavene JO; Yangba Mongba DS; Mbelesso P
    Bull Soc Pathol Exot; 2014 May; 107(2):106-9. PubMed ID: 24570116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections?
    Torok ME; Day JN; Hien TT; Farrar JJ
    AIDS; 2005 Mar; 19(5):535-6. PubMed ID: 15764862
    [No Abstract]   [Full Text] [Related]  

  • 31. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.
    Jarvis JN; Boulle A; Loyse A; Bicanic T; Rebe K; Williams A; Harrison TS; Meintjes G
    AIDS; 2009 Jun; 23(9):1182-3. PubMed ID: 19451796
    [No Abstract]   [Full Text] [Related]  

  • 32. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme.
    Lawn SD; Bekker LG; Myer L; Orrell C; Wood R
    AIDS; 2005 Nov; 19(17):2050-2. PubMed ID: 16260920
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fluconazole 1200mg or 800mg for cryptococcal meningitis treatment in Ivory Coast].
    Kouakou GA; Ello NF; Kassi NA; Keita M; Doumbia A; Mossou C; Kassi FK; Tanon A; Ehui E; Eholié SP
    J Mycol Med; 2017 Mar; 27(1):72-78. PubMed ID: 28108201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana.
    Opintan JA; Awadzi BK; Biney IJK; Ganu V; Doe R; Kenu E; Adu RF; Osei MM; Akumwena A; Grigg ME; Fahle GA; Newman MJ; Williamson PR; Lartey M
    Trans R Soc Trop Med Hyg; 2017 Oct; 111(10):464-471. PubMed ID: 29373741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptococcal meningitis associated with tuberculosis in HIV infected patients.
    Singh U; Aditi ; Aneja P; Kapoor BK; Singh SP; Purewal SS
    Indian J Tuberc; 2013 Jul; 60(3):180-3. PubMed ID: 24000497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Optimal Timing of Antiretroviral Therapy Initiation in HIV-Infected Patients with Cryptococcal Meningitis: A Multicenter Prospective Randomized Controlled Trial.
    Xu X; Lu Y; Harypursat V; Sun F; Zhao T; Zeng Y; He X; Chen Y
    Acta Med Okayama; 2021 Feb; 75(1):109-113. PubMed ID: 33649622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-adherence to antiretroviral therapy in patients infected with HIV and cryptococcal meningitis: two cases at the Lambaréné Hospital Center in Gabon.
    Kombila UD; Iba Ba J; Tsoumbou-Bakana G; Moussavou Kombila JB
    Med Sante Trop; 2016 Nov; 26(4):446-448. PubMed ID: 27919843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals.
    Balasko A; Keynan Y
    HIV Med; 2019 Jan; 20(1):1-10. PubMed ID: 30362282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
    Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
    BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of HIV-associated cryptococcal disease.
    Harrison TS
    AIDS; 2009 Feb; 23(4):531-2. PubMed ID: 19240459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.